DEVACREATION7
commented on
$Greenwave Technology Solutions(GWAV.US$ hawk tuah this thang. 🖕🏿🖕🏿🖕🏿🖕🏿
5
DEVACREATION7
liked
DEVACREATION7
commented on and voted
$Broadcom(AVGO.US$, which has soared 52% this year, will officially implement a 10-for-1 stock split plan after market close on July 12th (this Friday). This move follows $NVIDIA(NVDA.US$, another major AI player, and has sparked market speculation.
Let's compare the recent stock trends of NVIDIA and Broadcom. From the announcement to the actual split, NVIDIA's share price jumped about 27%, and it has risen an additi...
Let's compare the recent stock trends of NVIDIA and Broadcom. From the announcement to the actual split, NVIDIA's share price jumped about 27%, and it has risen an additi...
![Broadcom follows NVIDIA's lead in stock split. What's the aftermarket outlook?](https://ussnsimg.moomoo.com/sns_client_feed/77777025/20240711/1720686714613-65f626f6a7.png?area=999&is_public=true)
![Broadcom follows NVIDIA's lead in stock split. What's the aftermarket outlook?](https://ussnsimg.moomoo.com/sns_client_feed/77777025/20240711/1720686712501-ec7dfb6f80.png?area=999&is_public=true)
![Broadcom follows NVIDIA's lead in stock split. What's the aftermarket outlook?](https://ussnsimg.moomoo.com/sns_client_feed/77777025/20240711/1720686712660-292c950249.png?area=999&is_public=true)
+4
734
465
DEVACREATION7
liked
$Clearmind Medicine(CMND.US$
Clearmind Medicine to Present Groundbreaking Research at Psychedelic Medicine – Israel 2024 Conference
Clearmind Medicine (Nasdaq: CMND), a clinical-stage biotech firm, will present significant research at the Psychedelic Medicine – Israel 2024 conference in Tel Aviv from July 28-30. CEO Adi Zullof-Shani, Ph.D., will discuss the potential of 5-Methoxy-2-Aminoindane (MEAI) as a regulator of binge behaviors on July 29. Additionally, researchers Prof. Joseph Tam an...
Clearmind Medicine to Present Groundbreaking Research at Psychedelic Medicine – Israel 2024 Conference
Clearmind Medicine (Nasdaq: CMND), a clinical-stage biotech firm, will present significant research at the Psychedelic Medicine – Israel 2024 conference in Tel Aviv from July 28-30. CEO Adi Zullof-Shani, Ph.D., will discuss the potential of 5-Methoxy-2-Aminoindane (MEAI) as a regulator of binge behaviors on July 29. Additionally, researchers Prof. Joseph Tam an...
3
DEVACREATION7 : Not falling into the trick again if RS